CIK 0001237831
- Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043744954
- Phone
- +1 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,794,049
- in 3 filings, $425K under 10b5-1 plans
Net −$5,794,049. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | RHOADS ANN D Director | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −15,384 | 0 | ||
| 2021-01-14 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2021-01-14 | Lemaitre Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2021-01-14 | Davidar David D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2021-01-14 | ZARRILLI STEPHEN T Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2021-01-14 | TOBIN JAMES R Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2021-01-14 | Douglas Robert Andrew Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2021-01-14 | Huller Kelly SVP, GC, Corporate Secretary | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +30,000 | 30,000 | ||
| 2021-01-14 | Pfeil Keith W SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 | ||
| 2021-01-14 | Scavilla Daniel T EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +50,000 | 50,000 | ||
| 2021-01-14 | Demski David M President, CEO | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +175,000 | 175,000 | ||
| 2021-01-14 | Paul David C Executive Chairman | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +100,000 | 100,000 | ||
| 2020-12-28 | Huller Kelly SVP, GC, Corporate Secretary | Exercise or conversion | +2,000 | $11.28 | $23K | 2,000 |
| 2020-12-28 | Huller Kelly SVP, GC, Corporate Secretary | Sale | −2,000 | $66.15 | $132K | 0 |
| 2020-12-28 | Huller Kelly SVP, GC, Corporate Secretary | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −2,000 | 0 | ||
| 2020-12-17 | Demski David M President, CEO | Exercise or conversion | +15,864 | $24.10 | $382K | 164,719 |
| 2020-12-17 | Demski David M President, CEO | Sale | −164,719 | $64.20 | $10.6M | 0 |
| 2020-12-17 | Demski David M President, CEO | Exercise or conversion · Stock Option (Right to Buy Class A Common Stock) | −15,864 | 0 | ||
| 2020-12-16 | Demski David M President, CEO | Exercise or conversion | +3,125 | $43.77 | $137K | 151,980 |
| 2020-12-16 | Demski David M President, CEO | Exercise or conversion | +3,125 | $43.58 | $136K | 155,105 |
Page 16 of 25 · 498 trades